Hind Alkatan

King Saud University

Dr. Hind Manaa Alkatan, MD has completed her Saudi Ophthalmology Board (in the year 1994) from King Saud University (KSU), Riyadh, Saudi Arabia and her postdoctoral studies from Departments of Ophthalmology/Pathology, University of Manitoba and University of British Columbia, Canada (in the year 1999). She is an Associate Professor (College of Medicine), Consultant (Departments of Ophthalmology and Pathology), Chief of Ophthalmic Pathology Division, Director of the KSU Post-Graduate Residency & Fellowship Training Programs in Ophthalmology, and finally the Assistant Director for External Accreditation Unit, Postgraduate Medical Education Department, King Saud University, Riyadh, Saudi Arabia. She is a member in many international organizations in her field: Eastern Ophthalmic Pathology, Canadian Ophthalmology Society, International Society of Ocular Oncology, Ocular Oncology Group in addition to the local Saudi Ophthalmology Society. She contributes to other institutions such as being a Research Consultant at King Fahad Medical City in Riyadh. She has been contributing as an invited speaker in many international symposia such as the World Congress of Ophthalmology and the European Society of Pathology Annual meetings. She has published more than 140 papers in reputed journals and has been serving as an editorial board member for several journals including: Saudi Journal of Ophthalmology, World Journal of Ophthalmology, SRL Ophthalmology, The Scientific Pages of Ophthalmology and Academicians’ Research Center (ARC) Journal of Ophthalmology AJOM. AREAS OF INTEREST: Education, Medical Research, Ophthalmic Pathology and Ophthalmic Oncology.

1books edited

3chapters authored

Latest work with IntechOpen by Hind Alkatan

Retinoblastoma constitutes a global disease that burdens many families all over the world. This book highlights the essential basic information needed by every ophthalmologist and covers all aspects of this tumor: history, genetics, epidemiology, clinical features, diagnosis, imaging, management, and prognosis. The book includes basic knowledge, but is also designed to discuss current treatment modalities showing improved survival compared to the past. A whole chapter is dedicated to histopathological features and the American Joint Commission on Cancer staging system, with the aim of having it internationally used in all countries to improve outcomes and for research purposes. Readers will find the book enjoyable, comprehensive, and easy to understand.

Go to the book